New York, May 02, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Zollinger-Ellison Syndrome (Gastrinoma) Clinical Trial Analysis by Trial Phase, Trial Status, Trial ...
Gastrinomas are rare tumors forming in the pancreas or duodenum, which is the first part of the small intestine. These growths can form as a single tumor or group of tumors. They begin in the cells ...
This page lists all known medications that could potentially lead to 'Gastrinoma' as a side effect. It's important to note that mild side effects are quite common with medications. The medication(s) ...
Zollinger-Ellison syndrome (ZES) is a health condition that results from having a gastrinoma, or gastric tumor, that increases the production of stomach acid. Though some people may use ...
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Zollinger-Ellison Syndrome (Gastrinoma) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" drug ...
Yu and colleagues [19] performed a prospective study of 212 patients with ZES, 19% of whom had MEN-1. After a mean follow-up of 18 years, 145 (68%) were alive and 67 (32%) had died. Of the patients ...
Dublin, Nov. 06, 2024 (GLOBE NEWSWIRE) -- The "Zollinger-Ellison Syndrome (Gastrinoma) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering. The ...
Most patients with a sporadic gastrinoma present with symptoms of ZES. About 25% of these tumors are not localized preoperatively, even using a combination of CT scan, MRI, somatostatin receptor ...
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/2njhxw/zollingerellison) has announced the addition of the "Zollinger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback